ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

NCT02616497 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1220

Enrollment

OTHER

Sponsor class

Conditions

Atherothrombosis

Interventions

DRUG: Aspirin
DRUG: Triflusal

Sponsor

University of Ioannina